VF
SBFM

Virtu Financial’s Sunshine Biopharma SBFM Stock Holding History

Virtu Financial’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,339
Closed -$29K – 2221
2025
Q4 		$29K Buy
+2,339
New +$37K ﹤0.01% 1370
2024
Q1 		– Sell
-1
Closed -$6K – 2013
2023
Q4 		$6K Buy
+1
New +$5.69K ﹤0.01% 1459
2023
Q2 		– Sell
-1
Closed -$20K – 1970
2023
Q1 		$20K Sell
1
-1
-50% -$18.2K ﹤0.01% 1243
2022
Q4 		$23K Buy
+2
New +$31.9K ﹤0.01% 1240
2022
Q3 		– Sell
-2
Closed -$52K – 2173
2022
Q2 		$52K Buy
2
+1
+100% +$48.8K ﹤0.01% 1117
2022
Q1 		$34K Buy
+1
New +$48.7K ﹤0.01% 1216

Other funds holding SBFM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Virtu Financial's SBFM Position: Q1 2026 in Review

Virtu Financial sold out of Sunshine Biopharma (SBFM) in Q1 2026, closing a stake of 2,339 shares — an estimated $29K sold.

Virtu Financial first reported a position in SBFM in Q1 2022 and held it in 6 quarters. The position peaked at $52K in Q2 2022. 8 funds tracked by Wall St. Rank hold SBFM as of Q1 2026.

  • Virtu Financial reported no remaining Sunshine Biopharma position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 2,339 Sunshine Biopharma shares in Q1 2026, an estimated $29K.
  • Virtu Financial first reported a position in Sunshine Biopharma in Q1 2022 and held it in 6 quarters.
  • Virtu Financial's Sunshine Biopharma position peaked at $52K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.